Concepedia

Rick Duncan

RD

3

Publications

233

Citations

3

H-Index

2012

Active since

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Rick Duncan is an author at Alnylam Pharmaceuticals (United States) specializing in medicine, gene delivery, and nanomedicine.

Top concepts

Publications per year

2012–2012

3

Publications

3

Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells

Tatiana I. Novobrantseva, Anna Borodovsky, Jamie Wong et al. · Molecular Therapy — Nucleic Acids · 2012 · 135 citations · Full text

, , +28

Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression

Robert F. Place, Ji Wang, Emily J. Noonan et al. · Molecular Therapy — Nucleic Acids · 2012 · 57 citations · Full text

, , +16

Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo

Donald J. Foster, Scott Barros, Rick Duncan et al. · RNA · 2012 · 41 citations · Full text

, , +11

Rows per page

1–3 of 3